World journal of urology · 2026
Modifiable predictors of patency after microsurgical vasoepididymostomy: associations of adjunctive escin, prior percutaneous epididymal sperm aspiration, and postoperative ejaculatory frequency.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Jihai, Ju Yisong, Zhang Haoqiang, Qian Lei, Yue Qiuling, Gao Qingqiang, Song Tao, Yu Wen, Zhao Xiaozhi
Аннотация
PURPOSE: To examine associations of adjunctive oral escin, prior percutaneous epididymal sperm aspiration (PESA), and early postoperative ejaculatory frequency with time to and final technical patency after microsurgical vasoepididymostomy (MVE), and to derive an exploratory prognostic model for individualized counseling.
METHODS: We conducted a retrospective cohort study of 134 men with obstructive azoospermia (OA) who underwent MVE between June 2022 and August 2024. Patients received standard care alone (Control Cohort, n = 71) or standard care plus adjunctive oral escin (Combined Cohort, n = 63). Key variables included prior PESA and self-reported postoperative ejaculatory frequency during the first 3 months (< 2 vs. ≥2 times/week). Final technical patency was defined as the presence of any sperm in the ejaculate during follow-up. Time to patency was analyzed in the full cohort using Kaplan-Meier curves and multivariable Cox regression, with patients who remained non-patent by 12 months treated as right-censored observations at 12 months. Independent predictors of final technical patency were evaluated using multivariable logistic regression. To ensure model stability, an exploratory prognostic model was constructed using the independent predictors, and its discrimination was assessed by ROC analysis.
RESULTS: The Combined Cohort showed a higher final technical patency rate than the Control Cohort (87.3% vs. 73.2%, P = 0.043) and a shorter time to patency (log-rank P < 0.001). In multivariable Cox analysis, adjunctive escin was associated with earlier patency (HR = 1.645, P = 0.013), whereas prior PESA was independently associated with delayed patency (HR = 0.505, P = 0.001). Bilateral anastomosis (HR = 2.627, P = 0.006) and high postoperative ejaculatory frequency (HR = 1.916, P = 0.005) were also independently associated with earlier patency. In multivariable logistic regression, prior PESA was independently associated with lower final patency (OR = 0.238, P = 0.043), whereas bilateral anastomosis (OR = 5.039, P = 0.040) and high postoperative ejaculatory frequency (OR = 3.004, P = 0.041) were independently associated with higher final patency. The refined prognostic model demonstrated good discrimination (AUC = 0.778) and achieved an events-per-variable ratio of 9.0.
CONCLUSION: Modifiable perioperative factors were associated with MVE outcomes. Adjunctive escin was associated with earlier technical patency but not independently with final technical patency. High ejaculatory frequency during the first 3 months was associated with both earlier and higher final technical patency, whereas prior PESA was associated with delayed and lower patency. These findings may inform perioperative counseling, but should be interpreted as observational and exploratory.
METHODS: We conducted a retrospective cohort study of 134 men with obstructive azoospermia (OA) who underwent MVE between June 2022 and August 2024. Patients received standard care alone (Control Cohort, n = 71) or standard care plus adjunctive oral escin (Combined Cohort, n = 63). Key variables included prior PESA and self-reported postoperative ejaculatory frequency during the first 3 months (< 2 vs. ≥2 times/week). Final technical patency was defined as the presence of any sperm in the ejaculate during follow-up. Time to patency was analyzed in the full cohort using Kaplan-Meier curves and multivariable Cox regression, with patients who remained non-patent by 12 months treated as right-censored observations at 12 months. Independent predictors of final technical patency were evaluated using multivariable logistic regression. To ensure model stability, an exploratory prognostic model was constructed using the independent predictors, and its discrimination was assessed by ROC analysis.
RESULTS: The Combined Cohort showed a higher final technical patency rate than the Control Cohort (87.3% vs. 73.2%, P = 0.043) and a shorter time to patency (log-rank P < 0.001). In multivariable Cox analysis, adjunctive escin was associated with earlier patency (HR = 1.645, P = 0.013), whereas prior PESA was independently associated with delayed patency (HR = 0.505, P = 0.001). Bilateral anastomosis (HR = 2.627, P = 0.006) and high postoperative ejaculatory frequency (HR = 1.916, P = 0.005) were also independently associated with earlier patency. In multivariable logistic regression, prior PESA was independently associated with lower final patency (OR = 0.238, P = 0.043), whereas bilateral anastomosis (OR = 5.039, P = 0.040) and high postoperative ejaculatory frequency (OR = 3.004, P = 0.041) were independently associated with higher final patency. The refined prognostic model demonstrated good discrimination (AUC = 0.778) and achieved an events-per-variable ratio of 9.0.
CONCLUSION: Modifiable perioperative factors were associated with MVE outcomes. Adjunctive escin was associated with earlier technical patency but not independently with final technical patency. High ejaculatory frequency during the first 3 months was associated with both earlier and higher final technical patency, whereas prior PESA was associated with delayed and lower patency. These findings may inform perioperative counseling, but should be interpreted as observational and exploratory.